Nephrotoxicity Associated with Concomitant Use of Ledipasvir-Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection.
about
Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting.Acute Interstitial Nephritis Associated with Sofosbuvir and Daclatasvir.Drug interactions in HIV-infected patients treated for hepatitis C.Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients.Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamideLedipasvir and tenofovir drug interaction in human immunodeficiency virus-hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety.Sexual Dysfunction in a Patient Taking Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C: A Case Report.Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens.Acute Kidney Injury in Patients Undergoing Chronic Hepatitis C Virus Treatment With Ledipasvir/SofosbuvirGlomerular filtration rate change during chronic hepatitis C treatment with Sofosbuvir/Ledipasvir in HCV/HIV Coinfected patients treated with Tenofovir and a boosted protease inhibitor: an observational prospective study
P2860
Q33805907-5C508CCB-48F2-4D32-955A-FCA7A5895428Q40123251-22CA51B1-9154-492C-B81E-8C4254012776Q40143109-C1C73DCC-4BF8-4839-B16A-FB5B08AD5920Q40272838-2459F3A1-36C9-42B4-B2B2-6709F044DEB0Q41925730-E6FCC40F-B616-4F36-9711-8605D241690FQ45326406-B383702D-987F-4957-8648-CC413A745B55Q47571985-BC4AE819-54F9-4ABC-9D47-86F317FE0FE2Q49200882-91C5879A-FB74-4BA5-A0FB-6DAE42020209Q57070331-7543AE36-DB89-4C1C-B949-0F3591605A5AQ58801384-6C6B51E9-AAC6-4B21-9455-89FA2D33B0CA
P2860
Nephrotoxicity Associated with Concomitant Use of Ledipasvir-Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Nephrotoxicity Associated with ...... odeficiency Virus Coinfection.
@en
Nephrotoxicity Associated with ...... odeficiency Virus Coinfection.
@nl
type
label
Nephrotoxicity Associated with ...... odeficiency Virus Coinfection.
@en
Nephrotoxicity Associated with ...... odeficiency Virus Coinfection.
@nl
prefLabel
Nephrotoxicity Associated with ...... odeficiency Virus Coinfection.
@en
Nephrotoxicity Associated with ...... odeficiency Virus Coinfection.
@nl
P2093
P2860
P356
P1433
P1476
Nephrotoxicity Associated with ...... nodeficiency Virus Coinfection
@en
P2093
Albert M Osei
Gregory Huhn
Maureen A Gallagher
Robert C Glowacki
Sonia Vibhakar
P2860
P304
P356
10.1002/PHAR.1803
P407
P577
2016-09-01T00:00:00Z